• Home
  • Search Results

Search Results

374 studies match your search
Open

Building advocacy skills for parents of transition age youth with IDD

Parents are stressed out finding and managing health and nonmedical services for their transition aged children with intellectual and developmental disabilities. Building advocacy skills through peer-to-peer learning provides inspiration and life-long tools to address new questions and needs as they arise. Parents of youth aged 11-27 with IDD are invited to participate in this study. Parents will attend a group with other parents; the groups will meet 4 times, once a week for 1 hour.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Developmental
  • Parents of Children
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

Measuring body composition in childhood cancer

Have you or your child have been recently diagnosed with cancer? If so, you or your child may be able to take part in a research study looking at how muscle and physical function (strength, mobility, endurance) change in children and young adults undergoing cancer treatment.

Age & Gender
  • 8 years ~ 21 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers)
Open

Smoldering Multiple Myeloma Study

Do you have asymptomatic multiple myeloma, also known as smoldering multiple myeloma? You may be able to take part in a research study to help us learn more about the effectiveness of a drug called daratumumab in combination with lenalidomide and steroids.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Chronic Lymphocytic Leukemia Study

Do you have chronic lymphocytic leukemia and have not received a previous treatment for your cancer? You may be able to take part in a new research study comparing treatments for Chronic Lymphocytic Leukemia.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Leukemia)
Open

Trial of Intravesical Gemcitabine and Pembrolizumab in Bladder Cancer Patients

Have you been diagnosed with high-risk non-muscle invasive bladder cancer which has not responded to initial treatment with Bacillus Calmette-Guerin (BCG)? If so, you may be able to take part in a research study evaluating the safety of adding the study drug called pembrolizumab to an existing treatment option for bladder cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder)
Open

Study of a Combination of Chemotherapy and Immunotherapy for Bladder Cancer

Have you been diagnosed with bladder cancer? You may be able to take part in a research study looking at a combination of chemotherapy drugs given with immunotherapy for patients with muscle invasive bladder cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder)
  • Urinary and Bladder
Open

Relapsed or Refractory Leukemia Study

Do you have Leukemia and recent test results show that the signs and symptoms of your cancer have returned? Are you looking for another treatment option? In this study, we want to see if a study medication can treat your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Leukemia)
Open

Menopause and Heart Health Study

Are you experiencing symptoms of menopause? Have you noticed a change in your mood during your menopausal transition? If you have missed at least two periods, you may be able to take part in a research study. In this study, we want to learn how mood and stress may affect risk for heart disease in women during menopause.

Age & Gender
  • 44 years ~ 55 years
  • Female
Study Interest
  • Aging
  • Brain, Head, Nervous System
  • Glands and Hormones
  • and 6 more
Open

Biomarker for cervical cancer screening study

If so, you may be able to take part in a research study that aims to identify non-invasive biomarkers for cervical cancer screening and monitoring following treatment of abnormal areas on the cervix caused by HPV.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Cervical)
  • Immune System/Infections
  • Sexual and/or Reproductive Health
  • Women's Health
Open

A Study of Investigational Medication for Relapsed or Refractory Multiple Myeloma

Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research